期刊文献+

重组人凝血因子Ⅶa治疗心外科术后渗血患者32例的临床分析 被引量:1

下载PDF
导出
摘要 目的对心外科围术期应用重组人凝血因子Ⅶa治疗术后渗血进行临床分析。方法应用注射用重组人凝血因子Ⅶa治疗解放军总医院心外科2006年1月至2009年5月期间32例心外科手术后渗血患者,记录给药方法、剂量,观察心包纵膈引流量及凝血指标并进行统计学处理。结果重组人凝血因子Ⅶa平均剂量67.4μg.kg-1(30.8~90.9μg.kg-1),给药后28例达到止血效果,1例开胸探查,2例术后出现精神障碍,2例死亡。给药后引流量明显减少,给药后凝血功能指标明显改善。结论重组人凝血因子Ⅶa对改善心外科术后患者凝血功能障碍效果较好。
出处 《解放军药学学报》 CAS 2009年第6期553-554,共2页 Pharmaceutical Journal of Chinese People's Liberation Army
  • 相关文献

参考文献5

二级参考文献10

  • 1MCILROY D R, SILVERS A J, Recombinant factor Ⅶa for life-threatening bleeding in high-risk cardiac surgery despite full-dose aprotinin[ J ].Anesth Analg. 2004, 99 (1): 27-30.
  • 2LEVI M, PETERS M, BULLER H R. Efficacy and safety of recombinant factor Ⅶa for treatment of severe bleeding: a systematic review[ J ].Crit Care Med, 2005, 33 (4):883-890.
  • 3SORENSEN B, FENGER-ERIKSEN C, INGERSLEV J. Recombinant factor Ⅶa fails to correct coagulopathy induced by haemodilution with colloid[J]. Br J Anaesth, 2005, 94 (6): 862-863.
  • 4Gala B,Quintela J,Aguirrezabalaga J,et al.Benefits of recombinant activated factor Ⅶ in complicated liver transplantation[J].Transplant Proc,2005,37(9):3919 -3921.
  • 5Shao YF,Yang JM,Chau GY,et al.Safety and hemostatic effect of recombinant activated factor Ⅶ in cirrhotic patients undergoing partial hepatectomy:a multicenter,randomized,double-blind,placebo-controlled trial[J].Am J Surg,2006,191 (2):245 -249.
  • 6Ten Cate H,Bauer K,Levi M.The action of factor Ⅹ and prothrombin by recombinant factor Ⅶa in vivo is mediated by tissue factor[J].J Clin Invest,1993,92(5):1207-1212.
  • 7Hoffman M,Monroe Ⅲ DM,Roberts HR.Activated factor Ⅶ activates factors Ⅸ and Ⅹ on the surface of activated platelets:thoughts on the mechanism of action of high-dose activated factor Ⅶ[J].Blood Coagul Fibrinolysis,1998,9 (suppl 1):S61-S65.
  • 8Porte R J,Caldwell SH.The role of recombinant factor Ⅶa in liver transplantation[J].Liver T ranspl,2005,11 (8):872-874.
  • 9Shami V,Caldwell S,Hespenheide E,et al.Recombinant activated factor Ⅶ for coagulopathy in fulminant hepatic failure compared with conventional therapy[J].Liver Transpl,2003,9(2):138-143.
  • 10Fridberg MJ,Hedner U,Roberts HR,et al.A study of the pharmacokinetics and safety of recombinant activated factor Ⅶ in healthy Caucasian and Japanese subjects[J].Blood Coagul Fibrinolysis,2005,16(4):259-266.

共引文献1

同被引文献13

  • 1Kunio NR,Differding JA,Watson KM,et al. Thrombelastography- i-dentified coag- ulopathy is associated with increased mor- bidity andmortality after traumatic brain injury[J]. AM J Surg,2012,203(5) :584- 588.
  • 2Gerlach R,Krause M,Seifert V,et al. Hemostatic and hemorrhagic problems in neurosurgical patients[J]. Acta Neurochir, 2009,151 (8) :873- 900.
  • 3Tian HL,Chen H,Wu BS,et al. D- Dimer as a predictor of progres-sive hemorrhagic injury in patients with traumatic brain in- jury:analysis of 194 cases [J], Neurosurg Rev,2010,33(3) :359- 365.
  • 4Schnuriger B,Inaba K,Abdelsayed GA,et al. The impact of plate-lets on the pro- gression of traumatic intracranial hemor- rhage[J]. JTrauma, 2010,68 (4) : 881 - 885.
  • 5Lustenberger T,Talving P, Kobayashi L, et al. Early coagulopathy after isolated severe traumatic brain injury:relationship with hy-poperfusion challenged [J]. J Trauma, 2010,69(6) : 1410- 1414.
  • 6Wafaisade A,Lefering R,Tjardes T,et al. Acute coagnlopathy in isolated blunt trau- matic brain injury [J]. Neurocrit Care, 2010,12(2) :211- 219.
  • 7Tauber H, Innerhofer P, Breitkopf R, et al. Prevalence and impact of abnormal ROTEM (R)assays in severe blunt trau- ma:results of the "Diagnosis and Treat- ment of Trauma- Induced Coagulopathy (DIA-TRE- TIC)study " [J]. Brit J Anaesth,2011,107(3) :378- 387.
  • 8Gonzalez E,Kashuk JL,Moore EE,et al. Differentiation of enzymatic from platelet hypercoagulability using the novel thrombelastography parameter delta (delta) [J]. J Surg Res,2010,163 (1):96- 101.
  • 9Kashuk JL, Moore EE,Sawyer M,et al. Postiujury coagnlopathy management:goal directed resuscitation via POC thrombe- lastogra-phy[J]. Ann Surg, 2010,251 (4) : 604- 614.
  • 10Shakur H,Roberts R,Bautista R,et al. Effects of tranexamic acid on death,vas- cular occlusive events,and blood transfu- sion in trauma patients with significant haemorrhage (CRASH22) :a randomised, placebo-controlled trial [J]. Lancet, 2010,376 (9734) : 23-32.

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部